Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASPEN AEROGELS INCASPN · Entity 5645 | Director · President and CEO | March 08, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASPEN AEROGELS INC
Report date March 08, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 637,834 |
Reported balance
After 2026-03-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-08 · Tax withholding · Disposed 4,275 · Balance 637,834 F1: 1. Shares withheld by Registrant to satisfy minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs"). F2: Represents 438,349 shares of Common Stock and 199,485 RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: 1. Shares withheld by Registrant to satisfy minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSUs").
F2: Represents 438,349 shares of Common Stock and 199,485 RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2021 Filed Nov 4, 2021 01:28 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 5,760 | $53.87 | $310,291.20 |
DisclosureSEC source: 0001209191-21-062858 · doc4.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 697,970 F1 · kind: The sales of shares were effected pursuant to a Rule 10b5-1 trading plan of the Reporting Person adopted on August 9, 2021. F4 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $53.54 to $54.53 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F5 · balance_after: Represents 182,030 shares of common stock, 54,324 shares of restricted stock units and 461,616 shares of restricted common stock. Read SEC document |
| November 01, 2021 Filed Nov 4, 2021 01:28 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | SaleCommon Stock | 3,400 | $54.92 | $186,728.00 |
DisclosureSEC source: 0001209191-21-062858 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,730 F1 · kind: The sales of shares were effected pursuant to a Rule 10b5-1 trading plan of the Reporting Person adopted on August 9, 2021. F2 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $54.54 to $55.54 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: Represents 187,790 shares of common stock, 54,324 shares of restricted stock units and 461,616 shares of restricted common stock. Read SEC document |
| June 29, 2021 Filed Jul 1, 2021 22:43 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 461,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-044570 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730,011 F1 · shares: The reporting person was granted restricted shares of common stock (the "Award") pursuant to a Performance-Based Restricted Stock Agreement by and between Aspen Aerogels, Inc. and the reporting person subject to the 2014 Employee, Director and Consultant Equity Incentive Plan. In order for a tranche of this Award to vest, both time and performance vesting conditions must be satisfied. For the time vesting condition, a tranche will vest at the later of (i) three years from the grant date or (ii) one year from the date when an applicable performance hurdle is achieved, subject to a maximum five-year vesting period for shares with respect to which the performance hurdle has been achieved. With respect to the performance vesting condition, there are three tranches with different share price hurdles and a five-year total performance period. If a share price hurdle is not met after five years, the applicable tranche is forfeited. F2 · shares: (cont.) The share price hurdle is met by reference to a 30-day volume weighted average price (VWAP) that is maintained for 60 days (the "Share Price Hurdle"). The first tranche consists of 34% of the restricted shares of common stock granted under the Award, with the Share Price Hurdle equal to $43.33. The second tranche consists of 33% of the restricted shares of common stock granted under the Award, with the Share Price Hurdle equal to $64.99. The third tranche consists of 33% of the restricted shares of common stock granted under the Award, with the Share Price Hurdle equal to $86.65. F1 · price: The reporting person was granted restricted shares of common stock (the "Award") pursuant to a Performance-Based Restricted Stock Agreement by and between Aspen Aerogels, Inc. and the reporting person subject to the 2014 Employee, Director and Consultant Equity Incentive Plan. In order for a tranche of this Award to vest, both time and performance vesting conditions must be satisfied. For the time vesting condition, a tranche will vest at the later of (i) three years from the grant date or (ii) one year from the date when an applicable performance hurdle is achieved, subject to a maximum five-year vesting period for shares with respect to which the performance hurdle has been achieved. With respect to the performance vesting condition, there are three tranches with different share price hurdles and a five-year total performance period. If a share price hurdle is not met after five years, the applicable tranche is forfeited. F2 · price: (cont.) The share price hurdle is met by reference to a 30-day volume weighted average price (VWAP) that is maintained for 60 days (the "Share Price Hurdle"). The first tranche consists of 34% of the restricted shares of common stock granted under the Award, with the Share Price Hurdle equal to $43.33. The second tranche consists of 33% of the restricted shares of common stock granted under the Award, with the Share Price Hurdle equal to $64.99. The third tranche consists of 33% of the restricted shares of common stock granted under the Award, with the Share Price Hurdle equal to $86.65. F3 · balance_after: Represents 191,190 shares of common stock, 54,324 restricted stock units and 461,616 shares of restricted stock. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 21:39 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 11,112 | $22.25 | $247,242.00 |
DisclosureSEC source: 0001209191-21-016066 · doc4.xml · nonDerivative · entry 3 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,514 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of time-based restricted stock units ("RSUs"). F4 · balance_after: Represents 191,190 shares of Common Stock and 54,324 Restricted Stock Units. Read SEC document |
| February 27, 2021 Filed Mar 2, 2021 21:39 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 9,501 | $22.25 | $211,397.25 |
DisclosureSEC source: 0001209191-21-016066 · doc4.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,626 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of time-based restricted stock units ("RSUs"). F3 · balance_after: Represents 176,758 shares of Common Stock and 79,868 Restricted Stock Units. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:39 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 2,268 | $22.25 | $50,463.00 |
DisclosureSEC source: 0001209191-21-016066 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,127 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of time-based restricted stock units ("RSUs"). F2 · balance_after: Represents 153,890 shares of Common Stock and 112,237 Restricted Stock Units. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:12 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right to Buy) · Derivative | 40,175 | $0.00 Strike: $24.13 | $0.00 |
DisclosureSEC source: 0001209191-21-014858 · doc4.xml · derivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,175 Underlying: Common Stock · 40,175 shares Expires 2031-02-24 F3 · derivative.exercise_date: The options vest as to one-third of the shares on February 24, 2022, an additional one-third of the shares on February 24, 2023 and the remaining one-third of the shares on February 24, 2024. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:12 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 7,304 | $24.13 | $176,245.52 |
DisclosureSEC source: 0001209191-21-014858 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,395 F1 · shares: Each Restricted Stock Unit ("RSU") represents the right to receive one share of Common Stock upon vesting. The RSUs vest as to one-third of the shares on February 24, 2022, an additional one-third of the shares on February 24, 2023 and the remaining one-third of the shares on February 24, 2024. F2 · balance_after: Represents 148,833 shares of Common Stock and 119,562 Restricted Stock Units and excludes 78,125 restricted shares forfeited as of December 31, 2020. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:16 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 1,000 | $7.01 | $7,010.00 |
DisclosureSEC source: 0001209191-20-017649 · doc4.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,216 F2 · balance_after: Represents 148,833 shares of Common Stock, 112,258 RSUs and 78,125 restricted shares of Common Stock. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:16 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 1,000 | $7.35 | $7,350.00 |
DisclosureSEC source: 0001209191-20-017649 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,216 F1 · balance_after: Represents 147,833 shares of Common Stock, 112,258 Restricted Stock Units ("RSU") and 78,125 restricted shares of Common Stock. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 21:26 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 7,497 | $7.95 | $59,601.15 |
DisclosureSEC source: 0001209191-20-014458 · doc4.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,216 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSU"). F3 · balance_after: Represents 146,833 shares of Common Stock, 112,258 RSUs and 78,125 restricted shares of Common Stock. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:26 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | Tax withholdingCommon Stock | 9,695 | $7.92 | $76,784.40 |
DisclosureSEC source: 0001209191-20-014458 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,713 F1 · shares: Shares withheld by Registrant to satisfy the minimum statutory tax withholding requirements on vesting of Restricted Stock Units ("RSU"). F2 · balance_after: Represents 128,787 shares of Common Stock, 137,801 RSUs and 78,125 restricted shares of Common Stock. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:56 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right-to-Buy) · Derivative | 135,077 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001209191-20-013959 · doc4.xml · derivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,077 Underlying: Common Stock · 135,077 shares Expires 2030-02-26 F3 · derivative.exercise_date: The options vest as to one-third of the shares on February 26, 2021, an additional one-third of the shares on February 26, 2022 and the remaining one-third of the shares on February 26, 2023. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:56 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 21,976 | $8.02 | $176,247.52 |
DisclosureSEC source: 0001209191-20-013959 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,408 F1 · shares: Each Restricted Stock Unit ("RSU") represents the right to receive one share of common stock upon vesting. The RSUs vest as to one-third of the shares on February 26, 2021, an additional one-third of the shares on February 26, 2022 and the remaining one-third of the shares on February 26, 2023. F2 · balance_after: Represents 106,113 shares of Common Stock, 170,170 shares of Restricted Stock Units and 78,125 restricted shares of Common Stock. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:55 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Option (Right-to-Buy) · Derivative | 135,077 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001209191-20-013958 · doc4.xml · derivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,077 Underlying: Common Stock · 135,077 shares Expires 2030-02-26 F3 · derivative.exercise_date: The options vest as to one-third of the shares on February 26, 2021, an additional one-third of the shares on February 26, 2022 and the remaining one-third of the shares on February 26, 2023. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:55 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 21,976 | $8.02 | $176,247.52 |
DisclosureSEC source: 0001209191-20-013958 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,408 F1 · shares: Each Restricted Stock Unit ("RSU") represents the right to receive one share of common stock upon vesting. The RSUs vest as to one-third of the shares on February 26, 2021, an additional one-third of the shares on February 26, 2022 and the remaining one-third of the shares on February 26, 2023. F2 · balance_after: Represents 106,113 shares of Common Stock, 170,170 shares of Restricted Stock Units and 78,125 restricted shares of Common Stock. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:17 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 1,000 | $6.00 | $6,000.00 |
DisclosureSEC source: 0001209191-19-048510 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,432 F1 · balance_after: Comprises 148,194 Restricted Stock Units, 106,113 shares of Common Stock and 78,125 restricted shares of Common Stock. Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 20:53 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 1,009 | $6.15 | $6,205.35 |
DisclosureSEC source: 0001209191-19-044843 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,432 F1 · price: Average price with actual price ranging from $6.10 to $6.15 F2 · balance_after: Comprises 148,194 Restricted Stock Units, 105,113 shares of Common Stock and 78,125 restricted shares of Common Stock. Read SEC document |
| May 28, 2019 Filed May 29, 2019 20:26 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 1,000 | $4.70 | $4,700.00 |
DisclosureSEC source: 0001209191-19-033193 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,423 F1 · balance_after: Comprises 148,194 Restricted Stock Units, 104,104 shares of Common Stock and 78,125 restricted shares of Common Stock. Read SEC document |
| May 09, 2019 Filed May 10, 2019 20:33 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 5,000 | $4.65 | $23,250.00 |
DisclosureSEC source: 0001209191-19-028943 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,423 F1 · balance_after: Comprises 148,194 Restricted Stock Units, 103,104 shares of Common Stock and 78,125 restricted shares of Common Stock. Read SEC document |
| May 08, 2019 Filed May 9, 2019 20:26 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 1,380 | $4.59 | $6,334.20 |
DisclosureSEC source: 0001209191-19-028487 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,423 F1 · balance_after: Comprises 148,194 Restricted Stock Units, 98,104 shares of Common Stock and 78,125 restricted shares of Common Stock. Read SEC document |
| May 07, 2019 Filed May 8, 2019 20:32 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 5,100 | $4.60 | $23,460.00 |
DisclosureSEC source: 0001209191-19-028231 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,043 F1 · price: Average price with actual price ranging from $4.55 to $4.60. F2 · balance_after: Comprises 148,194 Restricted Stock Units, 96,724 shares of Common Stock and 78,125 restricted shares of Common Stock. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:45 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Options (Right to Buy) · Derivative | 195,478 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001209191-19-015232 · doc4.xml · derivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,478 Underlying: Common Stock · 195,478 shares Expires 2029-02-27 F3 · derivative.exercise_date: The options vest as to one-third of the shares on February 27, 2020, an additional one-third of the shares on February 27, 2021 and the remaining one-third of the shares on February 27, 2022. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:45 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 97,107 | $3.63 | $352,498.41 |
DisclosureSEC source: 0001209191-19-015232 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,943 F1 · shares: Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting. The RSUs vest as to one-third of the shares on February 27, 2020, an additional one-third of the shares on February 27, 2021 and the remaining one-third of the shares on February 27, 2022. F2 · balance_after: Comprises 173,737 Restricted Stock Units and 66,081 shares of Common Stock and 78,125 restricted shares of Common Stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:34 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantStock Options (Right to Buy) · Derivative | 158,206 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001209191-18-015988 · doc4.xml · derivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,206 Underlying: Common Stock · 158,206 shares Expires 2028-02-28 F3 · derivative.exercise_date: The options vest as to one-third of the shares on February 28, 2019, an additional one-third of the shares on February 28, 2020, and the remaining one-third of the shares on February 28, 2021. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:34 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | GrantCommon Stock | 76,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015988 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,836 F1 · shares: Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting. The RSUs vest as to one-third of the shares on February 28, 2019, an additional one-third of the shares on February 28, 2020, and the remaining one-third of the shares on February 28, 2021. F2 · balance_after: Comprises 90,149 restricted stock units, 52,562 shares of common stock and 78,125 restricted shares of common stock Read SEC document |
| August 09, 2017 Filed Aug 9, 2017 20:09 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 920 | $4.73 | $4,351.60 |
DisclosureSEC source: 0001209191-17-048245 · doc4.xml · nonDerivative · entry 2 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,206 Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:09 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 80 | $4.75 | $380.00 |
DisclosureSEC source: 0001209191-17-048245 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,286 F1 · balance_after: Comprises 20,407 restricted stock units, 45,674 shares of common stock and 78,125 restricted shares of common stock Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 11:23 UTC | ASPEN AEROGELS INC ASPN · Entity 5645 | PurchaseCommon Stock | 1,000 | $4.20 | $4,200.00 |
DisclosureSEC source: 0001209191-16-154572 · doc4.xml · nonDerivative · entry 1 Young Donald R · CIK 0001610257 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,206 F1 · balance_after: Comprises 27,038 restricted stock units, 38,043 shares of common stock and 78,125 restricted shares of common stock Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.